Peptilogics
Peptilogics is a clinical-stage biotechnology company based in Pittsburgh, PA, founded in 2013. The company focuses on peptide therapeutic discovery, utilizing machine learning and computational platforms to create innovative treatments for serious diseases. With a team of 28 employees and $44.1 million in funding, Peptilogics is committed to advancing its pipeline of anti-infective therapies. The company operates a proprietary computational drug discovery platform that accelerates the design and development of peptides. This platform leverages AI and machine learning to engineer peptides efficiently, addressing challenges associated with traditional methods. Peptilogics is particularly known for its eCAP technology, which improves the stability and efficacy of antimicrobial peptides, targeting serious infections and exploring additional disease areas. Led by CEO Jonathan Steckbeck, Peptilogics employs a recurring revenue model, partnering with clients in the biopharmaceutical sector to develop peptide-based therapeutics. The company is focused on scaling its operations and expanding its therapeutic offerings.
Work at Peptilogics in HR or recruiting? Claim this page
Headcount trend
Peptilogics went from 23 employees in Jul 2023 to 18 in Jun 2025. Jan to Jun 2025: 0 people joined, 3 left.
Headcount data through Jun 2025
Funding rounds
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Dec 2020 | Series B | $35.4M | 2 | |
| Feb 2020 | Funding | $2.6M | 2 | |
| Feb 2020 | Funding | – | 1 | |
| Sep 2017 | Series A | $5.5M | 2 | |
| Jan 2016 | Seed | $417K | – | – |
| Jan 2016 | Seed | $1.3M | – | – |
Org structure
Headcount by department
Peer reviews
Worked with someone at Peptilogics?
Anonymous peer reviews on OffTheRecord
Similar companies
Peptilogics FAQ
How many employees does Peptilogics have?
Peptilogics has about 18 employees, down 10% over the 3 months to Jun 2025.
How much funding has Peptilogics raised?
Peptilogics has raised $45.18M in total funding; its latest round was Series B in Dec 2020.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.